» Articles » PMID: 21589837

Hyperuricemia in Obese Children and Adolescents: the Relationship with Metabolic Syndrome

Overview
Journal Pediatr Rep
Publisher MDPI
Specialty Pediatrics
Date 2011 May 19
PMID 21589837
Citations 27
Authors
Affiliations
Soon will be listed here.
Abstract

The prevalence of hyperuricemia in obese children and adolescents and its association with metabolic syndrome are largely unknown. The objective of our study was to characterize hyperuricemia in relation to metabolic syndrome in Japanese children and adolescents with obesity. Between 2005 and 2008, we performed a cross-sectional study of 1,027 obese children and adolescents aged 6-14 years. Based on the reference value of serum uric acid we had established previously, hyperuricemia was defined as one standard deviation over the mean value at each age. The diagnosis of metabolic syndrome was made based on the Japanese criteria for children. A total of 213 children and adolescents (20.7%) was found to have hyperuricemia. The prevalence of hyperuricemia was significantly higher in the male gender and older age group. Sixty-five out of 213 subjects with hyperuricemia (30.5%) had metabolic syndrome, whereas 111 out of 814 subjects without hyperuricemia (13.6%) had metabolic syndrome. The most common abnormal component of metabolic syndrome was triglyceride, followed by diastolic blood pressure, systolic blood pressure, fasting blood glucose, and HDL-cholesterol. Such a tendency was almost identical between the two groups. We concluded that considering the association between hyperuricemia and metabolic syndrome in obese Japanese children and adolescents, the role of hyperuricemia in metabolic syndrome should receive more attention, beginning in early childhood.

Citing Articles

Prevalence of and trends in hyperuricemia by race and ethnicity among US adolescents, 1999-2018.

Guo K, Han Y, Liu S, Sun H, Lin X, Yang S Arthritis Res Ther. 2024; 26(1):193.

PMID: 39516855 PMC: 11545273. DOI: 10.1186/s13075-024-03427-1.


Association Between the Triglyceride-Glucose Index and Serum Uric Acid to High-Density Lipoprotein (HDL) Cholesterol Ratio in Type 2 Diabetes Mellitus in Gabes City, Tunisia.

Kwas H, Rajhi H, Rangareddy H Cureus. 2024; 16(8):e68235.

PMID: 39347128 PMC: 11439455. DOI: 10.7759/cureus.68235.


Lactoferrin in Pediatric Chronic Kidney Disease and Its Relationship with Cardiovascular Risk.

Ho C, Lu P, Chen W, Liao W, Hsu C, Tain Y Children (Basel). 2024; 11(9).

PMID: 39334656 PMC: 11431036. DOI: 10.3390/children11091124.


A Gender-, Age-, and Weight Status-Specific Analysis of the High Prevalence of Hyperuricemia Among Chinese Children and Adolescents with Obesity.

Liu M, Cao B, Luo Q, Song Y, Shi Y, Cheng M Diabetes Metab Syndr Obes. 2024; 17:381-391.

PMID: 38283639 PMC: 10821731. DOI: 10.2147/DMSO.S448638.


Association of serum uric acid Levels with metabolic syndromes in Korean adolescents.

Seo Y, Shim Y, Lee H, Hwang J Front Endocrinol (Lausanne). 2024; 14:1159248.

PMID: 38169712 PMC: 10758490. DOI: 10.3389/fendo.2023.1159248.


References
1.
Muntner P, Srinivasan S, Menke A, Patel D, Chen W, Berenson G . Impact of childhood metabolic syndrome components on the risk of elevated uric acid in adulthood: the Bogalusa Heart Study. Am J Med Sci. 2008; 335(5):332-7. DOI: 10.1097/MAJ.0b013e31815574a4. View

2.
Alper Jr A, Chen W, Yau L, Srinivasan S, Berenson G, Hamm L . Childhood uric acid predicts adult blood pressure: the Bogalusa Heart Study. Hypertension. 2004; 45(1):34-8. DOI: 10.1161/01.HYP.0000150783.79172.bb. View

3.
Ford E, Li C, Cook S, Choi H . Serum concentrations of uric acid and the metabolic syndrome among US children and adolescents. Circulation. 2007; 115(19):2526-32. DOI: 10.1161/CIRCULATIONAHA.106.657627. View

4.
Kuczmarski R, Ogden C, Guo S, Grummer-Strawn L, Flegal K, Mei Z . 2000 CDC Growth Charts for the United States: methods and development. Vital Health Stat 11. 2002; (246):1-190. View

5.
Tsouli S, Liberopoulos E, Mikhailidis D, Athyros V, Elisaf M . Elevated serum uric acid levels in metabolic syndrome: an active component or an innocent bystander?. Metabolism. 2006; 55(10):1293-301. DOI: 10.1016/j.metabol.2006.05.013. View